Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
Gallium GA-68 Gozetotide in Metastatic Castration-Sensitive Prostate Carcinoma: NCT07674771 Clinical Landscape Report 2026
18 September 2026
NCT07674771 clinical landscape for Metastatic Castration-Sensitive Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and deve…
9 min read
Sevoflurane in Kidney Failure, Chronic: NCT07678073 Clinical Landscape Report 2026
18 September 2026
NCT07678073 clinical landscape for Kidney Failure, Chronic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Darolutamide in Localized Prostate Carcinoma: NCT07677566 Clinical Landscape Report 2026
18 September 2026
NCT07677566 clinical landscape for Localized Prostate Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
LY-N001(Lingyi (Hangzhou) Biotechnology) in Parkinson Disease: NCT07685444 Clinical Landscape Report 2026
18 September 2026
NCT07685444 clinical landscape for Parkinson Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ontunisertib in Crohn Disease: NCT07683325 Clinical Landscape Report 2026
18 September 2026
NCT07683325 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Prilocaine Hydrochloride in Pain: NCT07683182 Clinical Landscape Report 2026
18 September 2026
NCT07683182 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ipilimumab in Locally Advanced Pancreatic Adenocarcinoma: NCT07683221 Clinical Landscape Report 2026
18 September 2026
NCT07683221 clinical landscape for Locally Advanced Pancreatic Adenocarcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development…
9 min read
IL-12 (SYTE) in Crohn Disease: NCT07686757 Clinical Landscape Report 2026
18 September 2026
NCT07686757 clinical landscape for Crohn Disease: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Acetaminophen/Ibuprofen in Pain: NCT07687394 Clinical Landscape Report 2026
18 September 2026
NCT07687394 clinical landscape for Pain: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Erythropoietin(Xiamen Amoytop Biotech Co. Ltd.) in Urologic Diseases: ISRCTN16119881 Clinical Landscape Report 2026
18 September 2026
ISRCTN16119881 clinical landscape for Urologic Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
EC-5026 in Chronic Kidney Diseases: NCT07694544 Clinical Landscape Report 2026
18 September 2026
NCT07694544 clinical landscape for Chronic Kidney Diseases: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
INT-210 in Colitis, Ulcerative: NCT07692165 Clinical Landscape Report 2026
18 September 2026
NCT07692165 clinical landscape for Colitis, Ulcerative: endpoints, sponsor, phase, geography, readouts, asset context and development white space.